Last reviewed · How we verify
Subtenon Injection of Autologous Platelet-Rich Plasma — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Subtenon Injection of Autologous Platelet-Rich Plasma (Subtenon Injection of Autologous Platelet-Rich Plasma) — Rubens Camargo Siqueira.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Subtenon Injection of Autologous Platelet-Rich Plasma TARGET | Subtenon Injection of Autologous Platelet-Rich Plasma | Rubens Camargo Siqueira | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Subtenon Injection of Autologous Platelet-Rich Plasma CI watch — RSS
- Subtenon Injection of Autologous Platelet-Rich Plasma CI watch — Atom
- Subtenon Injection of Autologous Platelet-Rich Plasma CI watch — JSON
- Subtenon Injection of Autologous Platelet-Rich Plasma alone — RSS
Cite this brief
Drug Landscape (2026). Subtenon Injection of Autologous Platelet-Rich Plasma — Competitive Intelligence Brief. https://druglandscape.com/ci/subtenon-injection-of-autologous-platelet-rich-plasma. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab